Skip to content
drillr.ai
Sign up

CLRB

Cellectar Biosciences, Inc.

NASDAQ · Healthcare · Biotechnology · US

$2.37
+0.85%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue—————
Cost of Revenue(110.0K)213.6K———
Gross Profit110.0K(213.6K)———
Operating Expenses
R&D Expense13.2M11.5M26.1M27.3M19.2M
SG&A Expense10.4M11.5M25.6M11.7M9.6M
General & Admin Expense7.5M11.5M25.6M11.7M9.6M
Selling & Marketing Expense—————
Other Expenses—(213.6K)———
Total Operating Expenses23.6M22.8M51.8M39.0M28.8M
Cost and Expenses23.5M23.0M51.8M39.0M28.8M
Operating Income (EBIT)(23.5M)(23.0M)(51.8M)(39.0M)(28.8M)
Non-Operating
Interest Income406.5K435.1K1.2M387.1K152.5K
Interest Expense—————
Net Interest Income406.5K435.1K1.2M387.1K152.5K
Other Non-Op Income/Expense1.2M1.2M7.3M(3.9M)(3.0M)
Non-Operating Income (excl Interest)(1.2M)(1.2M)(7.3M)3.9M3.0M
EBT (Pre-Tax Income)(22.3M)(21.8M)(44.5M)(42.8M)(31.9M)
Income Tax Expense——66.0K(60.0K)(60.0K)
Bottom Line
Net Income(22.3M)(21.8M)(44.6M)(42.8M)(31.8M)
Earnings from Cont. Ops(22.3M)(21.8M)(44.6M)(42.8M)(31.8M)
Earnings from Discont. Ops—————
Bottom Line Net Income(22.3M)(21.8M)(44.6M)(42.8M)(31.8M)
Per Share
Basic EPS($4.56)($8.35)($36.52)($104.99)($135.18)
Diluted EPS($4.56)($8.35)($41.89)($104.99)($135.18)
Revenue Per Share$0.00$0.00$0.00$0.00$0.00
Shares
Basic Shares Outstanding12.2M2.6M1.2M407385235188
Diluted Shares Outstanding12.2M2.6M1.2M407385235188
Profitability Metrics
EBITDA(22.3M)(21.6M)(44.2M)(42.6M)(31.7M)
D&A(8.3K)213.6K291.7K192.4K148.4K
EBIT(22.3M)(21.8M)(44.5M)(42.8M)(31.9M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026